Cargando…
Use of Batroxobin in Central and Peripheral Ischemic Vascular Diseases: A Systematic Review
Background and Purpose: The mechanism of action of Batroxobin included the decomposition of the fibrinogen to fibrin degradation products (FDPs) and D-dimer and mobilization of endothelial cells to release endogenous nt-PA and to promote thrombolysis. This review aims to summarize current study find...
Autores principales: | Lan, Duo, Song, Siying, Liu, Yunhuan, Jiao, Baolian, Meng, Ran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675357/ https://www.ncbi.nlm.nih.gov/pubmed/34925203 http://dx.doi.org/10.3389/fneur.2021.716778 |
Ejemplares similares
-
The BE COOL Treatments (Batroxobin, oxygEn, Conditioning, and cOOLing): Emerging Adjunct Therapies for Ischemic Cerebrovascular Disease
por: Song, Siying, et al.
Publicado: (2022) -
Remote ischemic conditioning-induced hyperacute and acute responses of plasma proteome in healthy young male adults: a quantitative proteomic analysis
por: Song, Siying, et al.
Publicado: (2023) -
Cerebral Venous-Associated Brain Damage May Lead to Anxiety and Depression
por: Lan, Duo, et al.
Publicado: (2022) -
Short-term effects of intravenous batroxobin in treatment of sudden sensorineural hearing loss: a propensity score-matched study
por: Jiang, Mengzhu, et al.
Publicado: (2023) -
Batroxobin inhibits astrocyte activation following nigrostriatal pathway injury
por: Zhang, Zhuo, et al.
Publicado: (2020)